Associations between COVID-19 Vaccination Hesitancy, Related Barriers and Some Sociodemographic Factors in Duhok City, Iraq
Keywords:
COVID-19 Vaccination , Hesitancy , Barriers , Sociodemographic factors , Duhok Province , IraqAbstract
The most crucial public health achievement of humanity is vaccination. Conversely, a significant portion of the population remains hesitant regarding vaccines. The purpose of the study is to determine the prevalence and the reasons that affect the rate of vaccination against COVID-19, which is caused by virus named SARS-CoV-2, in Duhok City. A cross-sectional survey was conducted online from (November to January 2022), about 2015 participants were enrolled. The data were collected through a designated online questionnaire using Google Forms. The study results showed that females were more accessible to the vaccine (50.8%) than males (44.5%). More than half of the participants (n= 1147, 56.9%) were aged between 20–29 years. The majority of participants were from Duhok (n= 799, 39.7%), followed by Zakho (n= 691, 34.3%), and fewer from Bardarash (n= 30, 1.5%). Moreover, the study revealed that the acceptance of the vaccine was more associated with young people, female gender, those with high educational levels, healthcare workers, and residents of Batifa district. To conclude, more than half of enrolled research individuals rejected to have the vaccine for COVID-19, Thus, we recommend integrating health and psychological care into vaccination plans to help increase the uptake rate during potential subsequent pandemics. Also, Psychologists can provide awareness messages, counselling seminars, online mentoring, or telemental health outreach. Furthermore, Governments must progress announcements also raising confidence concerning to health problems through the dispersion of scientific culture and improve educational programs in society.
References
[1] Alatrany, S.S.; Ogden, R.; Falaiyah, A.M.; ALdrraji, H.A.S.; Alatrany, A.S.; “The passage of time in Iraq during the covid-19 pandemic”. PloS one, 17(4), 2022. https://doi.org/10.1371/journal.pone.0266877.
[2] Guan, WJ,; Ni, Z.Y,; Hu, Y,; Liang, W.H.; Ou, C.Q,; He, J.X.; Liu, L/; Shan, H.; Lei, C..; Hui, D.S.; Du, B.; “Clinical characteristics of coronavirus disease 2019 in China”. N Engl J Med, 382(18): 1708-1720, 2020. https://doi.org/10.1056/NEJMoa2002032.
[3] Shereen, M.A.; Khan, S.; Kazmi, A.; Bashir, N.; Siddique, R.; “COVID-19 infection: Emergence, transmission, and characteristics of human coronaviruses”. J. Adv. Res., 24: 91-98, 2020. https://doi.org/10.1016/j.jare.2020.03.005.
[4] Rauf. A.; Abu-Izneid, T.; Olatunde, A.; Ahmed, K. A.; Alhumaydhi, F.A.; Tufail, T., Shariati, M.A.; Rebezov, M.; Almarhoon, Z.M; Mabkhot, Y.N.; Alsayari, A.; “COVID-19 pandemic: epidemiology, etiology, conventional and non-conventional therapies”. Int. J. Environ. Res. Public Health, 17(21): 8155, 2020. https://doi.org/10.3390/ijerph17218155
[5] Sardu, J.; Gambardella, M.B.; Morelli, X.; Wang, R., Marfella; Santulli, G.; “Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence”. J. Clin. Med., 9(5): 1417, 2020. https://doi.org/10.3390/jcm9051417.
[6] Sardu, C.; Gambardella, J.; Morelli, M.B.; Wang, X.; Marfella, R; Santulli, G.; “COVID-19 vaccine roll-out in South Africa and Zimbabwe: Urgent need to address community preparedness, fears and hesitancy”. Vaccines; 9 (3): 250, 2021.
[7] Neumann-Böhme, S.; Varghese, N.E.; Sabat, I.; Barros, P.P.; Brouwer, W.; van Exel, J.; Schreyögg, J.; and Stargardt, T.; “Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19”. Eur. J. Health Econ, 21: 977-982, 2020.
https://link.springer.com/article/10.1007/s10198-020-01208-6.
[8] Neumann-Böhme, S.; Varghese, N.E.; Sabat, I.; Barros, P.P.; Brouwer, W.; van Exel, J., Schreyögg, J.; Stargardt, T.; “Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: A national cross-sectional study”. Vaccine, 39(21): 2833-2842, 2021. https://doi.org/10.1016/j.vaccine.2021.04.020.
[9] Qunaibi, E.A.; Helmy, M., Basheti, I.; Sultan, I.; “A high rate of COVID-19 vaccine hesitancy in a large-scale survey on Arabs”. Elife, 10, e68038., 2021. https://doi.org/10.7554/eLife.68038
[10] Abdulah, D.M.; “Prevalence and correlates of COVID‐19 vaccine hesitancy in the general public in Iraqi Kurdistan: A cross‐sectional study”. J. Med. Virol, 93(12): 6722-6731, 2021.
https://doi.org/10.1002/jmv.27255.
[11] Melhum, A. I., Mohammed, J. A. “Adaptive neuro-fuzzy inference system for estimation of water quality index in Duhok camps”. J. Univ. Duhok, 22(1):113-123, 2019.
https://doi.org/10.26682/sjuod.2019.22.1.13.
[12] World Health Organization, Ten threats to global health in 2019. 2019. https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019
[13] Abdullah, R.Y.; Tahir, A.I.; Ramadhan, D.S.; Mustafa, Z.R.; Galary, K.M.; “COVID-19 Vaccines Side Effects among Iraqi people In Kurdistan Region”: A cross-sectional study. Napoli. Cam. Nursing.1-22, 2022. https://doi.org/10.32549/OPI-NSC-63.
[14] Tahir, A.I.; Ramadhan, D.S.; Taha, A.A.; Abdullah, R.Y.; Karim, S.K.; Ahmed, A.K; Ahmed, S.F.; “Public fear of COVID-19 vaccines in Iraqi Kurdistan region: a cross-sectional study”. Middle East Curr. Psychiatr., 28: 1-8, 2021. https://link.springer.com/article/10.1186/s43045-021-00126-4
[15] Ahmed, W.; Vidal-Alaball, J.; Downing, J.; Seguí, F.L.; “Dangerous messages or satire? analysing the conspiracy theory linking 5g to covid-19 through social network analysis”. J Med Internet Res, 22(5): 2020.
https://doi.org/10.2196/preprints.19458
[16] Almufty, H.B.; Mohammed, S.A.; Abdullah, A.M.; Merza, M.A.; “Potential adverse effects of COVID19 vaccines among Iraqi population; a comparison between the three available vaccines in Iraq; a retrospective cross-sectional study. Diabetes Metab Syndr, 15(5): 102-207, 2021. https://doi.org/10.1016/j.dsx.2021.102207.
[17] Ahmad, K.K.; “Coronavirus disease 2019 vaccine hesitancy in the Kurdistan region: A cross-sectional national survey”. Arch. Razi Inst, 76(4): 751-759, 2021. https://doi.org/10.22092/ari.2021.355737.1714.
[18] Tahir, A.I.; Ramadhan, D.S.; Piro, S.S., Abdullah, R.Y.; Taha, A.A.; Radha, R.H.; “COVID-19 vaccine acceptance, hesitancy, and refusal among Iraqi Kurdish population”. Int. J. Health Sci, 16(1): 1-10, 2022. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721214.
[19] Shareef, L.G.; Al-Hussainy, A.F. and Hameed, S.M.; “COVID-19 vaccination hesitancy among Iraqi general population between beliefs and barriers: An observational study”. F1000Res, 2022, 11:334 last updated: 27 apr 2022. https://doi.org/10.12688%2Ff1000research.110545.2.
[20] Musgrove, A.T.; Powers, J.R.; Rebar, L.C.; Musgrove, G.J.; Real or fake? Resources for teaching college students how to identify fake news. Coll. Undergrad. Libr. 25(3):243–260, 2018. https://doi.org/10.1080/10691316.2018.1480444.
[21] Malik, A.A.; McFadden, S.M.; Elharake, J.; Omer, S.B.; “Determinants of COVID-19 vaccine acceptance in the US”. E.Clinical.Medicine, 26: 100-495, (2020). https://doi.org/10.1016/j.eclinm.2020.100495.
[22] Salah, H.M.; Sharma, T.; Mehta, J.; “Smoking doubles the mortality risk in COVID-19: a meta-analysis of recent reports and potential mechanisms”. Cureus, 12(10): 2020.
https://doi.org/10.7759/cureus.10837.
[23] Luma, A.H.; Haveen, A.H.; Faiq, B.B.; Stefania, M.; Leonardo, E.G., “Hesitancy towards Covid-19 vaccination among the healthcare workers in Iraqi Kurdistan. Protec.Human Res.Participants, 3: 100-222, 2022. https://doi.org/10.1016/j.puhip.2021.100222.
[24] Qunaibi, E.; Basheti, I.,;Soudy, M.; Sultan, I.; “Hesitancy of Arab healthcare workers towards COVID-19 vaccination: a large-scale multinational study”. Vaccines, 9(5): 446, 2021.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Sarwin Sultan Muhamad Mizuri, Dler Salih Ibrahim
This work is licensed under a Creative Commons Attribution 4.0 International License.
.jpg)
